FDA requires lower recommended doses for drugs containing zolpidem

Author(s):

On Jan. 10, 2012, the U.S. Food and Drug Administration (FDA) announced it is requiring the manufacturers of Ambien, Ambien CR, Edluar and Zolpimist, sleep drugs that contain the active ingredient zolpidem, to lower current recommended doses. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here